WASHINGTON, Dec 23 (Reuters) - Enrollment for health insurance under the U. Affordable Care Act dipped to 15.

Dec 23 () - A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a ​long-term study died after experiencing serious side effects, the ‌company said. The individual died on December 14 after suffering a stroke followed by ‌a brain hemorrhage, according to the European Haemophilia Consortium, a patient support group.

Dec 10 (Reuters) - A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial treatments, potentially allowing patients to avoid grueling bone marrow transplants, preliminary data from a small mid-stage trial suggest. Patients in the trial had received initial treatments that eliminated nearly all of their cancer cells.